医生推荐一名患者获200元好处费 肿瘤基因检测灰色内幕曝光

Group 1 - The article reveals a case of commercial bribery in the genetic testing industry, where a doctor received 200 yuan for each patient referred to a genetic testing company, resulting in a total of 116,200 yuan in kickbacks over a period [3][4] - The involved company, Shanghai Zhiben Medical Testing Co., Ltd., was found to have engaged in unfair competition by violating the Anti-Unfair Competition Law of the People's Republic of China, leading to a total penalty of 3.292 million yuan, including the confiscation of illegal gains [3][4] - The case was initiated by a patient complaint, which led to an investigation uncovering the company's attempts to disguise bribery through false reimbursements and hidden fund flows [4] Group 2 - Shanghai Zhiben Medical Testing Co., Ltd. is a prominent startup in the tumor genetic testing field, having received investments from well-known firms and completed a Series C financing round in 2021 [5] - The company has faced significant operational challenges, including a sharp decline in business revenue and a decision to suspend operations due to malicious freezing of accounts by certain shareholders [4][5] - The genetic testing market is described as a trillion-yuan industry, where some companies resort to illegal practices like kickbacks to gain market share, which undermines patient rights and threatens the credibility of the medical industry [5]